Table 2. Modality of response/resistance to first-line VEGF/VEGFR inhibitors and possible second-line treatment options to be explored. Clinical response to first-line therapy Putative molecular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback